Fresenius Ev To Operating Cash Flow from 2010 to 2025
| FMS Stock | USD 23.82 0.07 0.29% |
EV To Operating Cash Flow | First Reported 2010-12-31 | Previous Quarter 9.50370483 | Current Value 16.36 | Quarterly Volatility 4.04176447 |
Check Fresenius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresenius Medical's main balance sheet or income statement drivers, such as Interest Expense of 268.2 M, Total Revenue of 11.7 B or Gross Profit of 3.7 B, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0285 or PTB Ratio of 0.84. Fresenius financial statements analysis is a perfect complement when working with Fresenius Medical Valuation or Volatility modules.
Fresenius | Ev To Operating Cash Flow | Build AI portfolio with Fresenius Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.